Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim (Q48468871)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 1985

edit

Language	Label	Description	Also known as
English	Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim	scientific article published in July 1985

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

title

Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

author name string

Araki H

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

Kawashima K

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

Uchiyama Y

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

Aihara H

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

language of work or name

English

0 references

publication date

1 July 1985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

published in

European Journal of Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

volume

113

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

page(s)

313-318

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

Identifiers

DOI

10.1016/0014-2999(85)90078-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

PubMed publication ID

3930265

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3930265

retrieved

11 February 2018

reference URL

http://europepmc.org/abstract/MED/3930265

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48468871&oldid=2199678705"